Buprenorphine Decreases the CCL2-Mediated Chemotactic Response of Monocytes

Journal of Immunology - United States
doi 10.4049/jimmunol.1302647
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Specificity and Reversibility of Chemotactic Deactivation of Human Monocytes.

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
1981English

CEACAM1 Regulates the IL-6 Mediated Fever Response to LPS Through the RP105 Receptor in Murine Monocytes

BMC Immunology
Immunology
2019English

IgA RECEPTOR MEDIATED ACTIVATION OF HUMAN MONOCYTES

Pediatric Research
Child HealthPediatricsPerinatology
1987English

Response: Integrating Buprenorphine Therapy Into Clinical Practice

Science & Practice Perspectives
2004English

Involvement of TRPC Channels in CCL2-Mediated Neuroprotection Against Tat Toxicity

Journal of Neuroscience
Neuroscience
2009English

Buprenorphine Disrupts Sleep and Decreases Adenosine Concentrations in Sleep-Regulating Brain Regions of Sprague Dawley Rat

Anesthesiology
AnesthesiologyPain Medicine
2011English

Conformational Investigations on Analogs of Inflammation Response Inducing Chemotactic Tripeptide fMLP

Biopolymers
BiochemistryMedicineBiomaterialsOrganic ChemistryBiophysics
2005English

The Urokinase Receptor (CD87) Facilitates CD11b/CD18-mediated Adhesion of Human Monocytes.

Journal of Clinical Investigation
Medicine
1996English

-Tocopherol Decreases Interleukin-1 Release From Activated Human Monocytes by Inhibition of 5-Lipoxygenase

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy